ATP-sensitive potassium channel Created 2026-10-14 Updated 2026-11-05
An ATP-sensitive potassium channel couples membrane potassium conductance to cellular nucleotide state. A familiar pancreatic complex combines Kir6.2 pore subunits with SUR1 regulatory subunits. Increased intracellular ATP tends to inhibit channel opening; in a pancreatic beta cell, reduced potassium conductance can promote membrane depolarization and subsequent insulin secretion. Nucleotide regulation therefore links glucose metabolism to electrical activity, with regulatory-subunit and nucleotide-context dependence. [ref]
Glucagon-like peptide-1 receptor Created 2026-10-14 Updated 2026-11-05
The glucagon-like peptide-1 receptor is a G protein-coupled receptor activated by GLP-1, an intestinal peptide signal. In pancreatic beta cells, it can enhance glucose-dependent insulin secretion, prominently through cyclic AMP-linked pathways. It is distinct from the glucagon receptor despite their related ligands and receptor family. Tissue expression and physiological context determine which downstream response dominates. [ref]
Insulin secretion Created 2026-10-31 Updated 2026-11-05
Insulin secretion releases stored insulin from pancreatic beta cells through regulated exocytosis. Glucose metabolism can increase the ATP-to-ADP balance, reduce activity of an ATP-sensitive potassium channel, promote depolarization and stimulate calcium-dependent release. Additional inputs modulate the response. Secretion is distinct from insulin synthesis and from peripheral insulin action, so a higher circulating concentration alone does not locate the underlying change. [ref]
Diabetes is a disorder of glucose regulation with persistent hyperglycaemia; the glycosuria is a consequence, not a sufficient explanation of its cause. In 1865 the relation between hepatic glycogen, circulating glucose and urinary sugar was actively disputed. A contemporary account could reasonably discuss failure to assimilate food and excessive delivery of sugar from the liver; it could not possess the later demonstration of insulin deficiency. An 1863 discussion of diabetes documents competing interpretations of the hepatic experiments, rather than an agreed single lesion.[ref]
In the modern account, type 1 diabetes results from destruction of pancreatic beta cells and severe deficiency of insulin. Type 2 diabetes combines insulin resistance with inadequate compensatory insulin secretion. Disease of the pancreas can also cause diabetes. Reduced restraint of hepatic glucose production and impaired peripheral disposal of glucose contribute to hyperglycaemia. These mechanisms distinguish types that were not separated in the question's terminology.[ref]
When the filtered glucose load exceeds renal reabsorptive capacity, glycosuria causes an osmotic diuresis: loss of water and electrolytes produces polyuria, dehydration and polydipsia. Inadequate use of fuels and increased breakdown of stored fat and protein explain wasting despite appetite. Severe insulin deficiency promotes ketogenesis and can cause diabetic ketoacidosis; it is not correct to make this the inevitable state of everyone with diabetes. Conversely, renal glycosuria can occur without the systemic metabolic disorder, so a urinary sugar test alone does not settle the diagnosis.Symptoms and signs; complications: glycosuria and osmotic diuresis[ref]
The associated diseases should be separated into predispositions, complications and coincident illnesses. Pulmonary wasting called “phthisis” was prominent in period accounts, but the historical label does not establish that every reported lung cavity was tuberculous.[ref] Modern diabetes increases susceptibility to active tuberculosis; it does not convert sugar into tubercle. Diabetes also increases susceptibility to some other infections and can accompany recurrent skin infection, poor wound healing and gangrene.[ref] Long-standing hyperglycaemia is associated with retinopathy, nephropathy and peripheral neuropathy; accelerated atherosclerosis contributes to coronary artery disease, stroke and limb ischemia. Obesity is commonly associated with type 2 diabetes, although severe untreated disease may cause loss of body mass. None of these associations licenses a claim that every diabetic patient has the same anatomical lesions.[ref]
For an 1865 investigation, repeated urine testing could demonstrate reducing sugar and its variation with diet; simultaneous study of the blood and liver was needed to investigate the source. The distinction between glucose already present during life and glucose formed in an unfixed liver after death is crucial experimental design: post-mortem chemical change must not be mistaken for the living organ's output. Modern diagnosis measures blood glucose and longer-term glycaemic exposure rather than inferring the entire disorder from the taste or appearance of urine.[ref]